Abstract
ABSTRACT Differentiation of postsurgical or postradiation necrosis from tumor recurrence is a clinical dilemma. Magnetic resonance imaging does not always perform well in this setting. Several nuclear medicine techniques are available that offer a solution in such a clinical situation. We report a case where F-18 flurodeoxyglucose (FDG) and F-18 fluorothymidine (FLT) PET/CT were used to identify recurrence of a glioma. How to cite this article Kashyap R, Tiwari MK, Senthil R, Bhattacharya A, Gupta V, Mittal BR. Utility of F-18 Fluorothymidine PET Over F-18 Fluorodeoxyglucose PET/CT in Detection of a Recurrent Glioma. J Postgrad Med Edu Res 2012;46(4):202-203.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Postgraduate Medicine, Education and Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
